Antigen Detection Test Saliva - Goffin Molecular Technologies

Antigen Detection Test - Saliva

This rapid test makes it possible for people who can not do the sampling swab, to do a corona test.
This test would be great for children and disabled people. It is also ideal for people that need to test often.
Just a bit of saliva as a sample and 15 minutes later you have the results.

The antigen detection test of NewGene makes use of saliva as the sample and is therefore a non-invasive rapid test. The COVID-19 Antigen Detection Kit is an immunochromatographic membrane assay that uses highly sensitive monoclonal antibodies to detect nucleocapsid protein from SARS-CoV-2. The reagent pad contains the colloidal-gold conjugated with the monoclonal antibody against the nucleocapsid protein of SARS-CoV-2. The reaction membrane contains the secondary antibodies for nucleocapsid protein of SARS-CoV-2. With this method there a just a few drops of saliva and extraction buffer needed and the results show in 15 minutes. The test does not have to be performed by a trained person. It can be used by everyone, including private use.

FEATURES

Non-invasive
Sensitivity 97,3%
Specificity 99,2%
Easy to operate
No equipment required
CE-IVD approved

BENEFITS

SALIVA AS SAMPLE. The sampling of this kit makes it super easy and non-invasive. It also makes the test user-friendly.
ON-SITE. With this kit, it is possible to take a corona test in any place.
EASY. Everyone can take the test because of the simple design.

Goffin Molecular Technologies is an authorized distributor of NewGene.

Like Abbott, Roche, and Quidel, this test is registered in Europe and in possession of a valid CE and TüV certificate. This test also meets the minimum requirements of the RKI and PEI (the German RIVM) and is included in the BfArM list. The Federal Institute for Drugs and Medical Devices is an independent higher federal authority within the portfolio of the Federal Ministry of Health in Germany. The NewGene saliva test has been registered in several countries including France, Italy, Portugal, Czech Republic, Belgium, Greece, Peru, and Argentina. And more countries (including Switzerland) are busy validating this easy quick test. CE certification for use as a consumer self-test has been requested. Due to the non-invasive sample collection, the rapid test is also ideal for use on children, the elderly, persons with disabilities.

Goffin Molecular Technologies is not liable for incorrect use, storage, results, and explanation of the rapid test and any resulting calamities.

Deze test is net zoals Abbott, Roche en Quidel geregistreerd in Europa en in bezit van een geldig CE en TüV certificaat. Ook voldoet deze test aan de minimum eisen van de RKI en PEI (het Duitse RIVM) en is opgenomen in de BfArM-lijst. Het Federaal Instituut voor Drugs en Medische Hulpmiddelen is een onafhankelijke hogere federale autoriteit binnen de portefeuille van het Federale Ministerie van Volksgezondheid in Duitsland. De NewGene speekseltest is in meerdere landen geregistreerd waaronder: Frankrijk, Italië, Portugal, Tsjechië, België, Griekenland, Peru en Argentinië. En meer landen (o.a Zwitserland) zijn druk bezig met het valideren van deze gemakkelijke sneltest. Een CE-certificering voor gebruikt als zelftest voor consumenten is aangevraagd. Vanwege de niet-invasieve monsterafname is de sneltest ook ideaal voor gebruik bij kinderen, ouderen, personen met een handicap.

Goffin Molecular Technologies is niet aansprakelijk voor verkeerd gebruik, opslag, uitslag en uitleg van de sneltest en de eventueel daaruit voortvloeiende calamiteiten.